Literature DB >> 17420352

Predictors of outcome in chronic thromboembolic pulmonary hypertension.

Diana Bonderman1, Nika Skoro-Sajer, Johannes Jakowitsch, Christopher Adlbrecht, Daniela Dunkler, Sharokh Taghavi, Walter Klepetko, Meinhard Kneussl, Irene M Lang.   

Abstract

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by intraluminal thrombus organization and fibrous obliteration of pulmonary arteries. Recently, associated medical conditions such as splenectomy, ventriculoatrial shunt for the treatment of hydrocephalus, permanent central intravenous lines, inflammatory bowel disease, and osteomyelitis were found to be associated with the development of CTEPH. The study aim was to define the impact of these novel risk factors on survival. METHODS AND
RESULTS: Between January 1992 and December 2006, 181 patients diagnosed with CTEPH were tracked with the use of our center's customized computer database. A Cox regression model was used to examine relations between survival and associated medical conditions, age, sex, hemodynamic parameters, modified New York Heart Association functional class at diagnosis, CTEPH type, pulmonary endarterectomy, and anti-cardiolipin antibodies/lupus anticoagulant. During a median observation time of 22.1 (range, 0.03 to 152) months, the clinical end point of cardiovascular death or lung transplantation occurred in 48 cases (27%). Pulmonary endarterectomy (hazard ratio, 0.14; 95% CI, 0.05 to 0.41; P=0.0003), associated medical conditions (hazard ratio, 3.17; 95% CI, 1.70 to 5.92; P=0.0003), and pulmonary vascular resistance (hazard ratio, 1.02; 95% CI, 1.00 to 1.04; P=0.04) were predictors of survival. Thirty-day postoperative mortality (24% versus 9%) and the incidence of postoperative pulmonary hypertension (92% versus 20%) were substantially higher in patients with associated medical conditions.
CONCLUSIONS: CTEPH-predisposing medical conditions, such as splenectomy, permanent central intravenous lines, and certain inflammatory disorders, predict poor survival in CTEPH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420352     DOI: 10.1161/CIRCULATIONAHA.106.661041

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Bastiaan E Scholzel; Martijn C Post; H W Thijs Plokker; Repke J Snijder
Journal:  Lung       Date:  2011-12-08       Impact factor: 2.584

2.  [Computer-assisted diagnostic procedure for multislice computed tomography for assessment of the pulmonary arterial circulation. Clinical relevance].

Authors:  A Malich; D Hentrich; A Hansch; J Böttcher; U Teichgräber
Journal:  Radiologe       Date:  2012-04       Impact factor: 0.635

3.  Impact of pulmonary endarterectomy on pulmonary arterial wave propagation and reservoir function.

Authors:  Junjing Su; Alun D Hughes; Ulf Simonsen; Jens Erik Nielsen-Kudsk; Kim H Parker; Luke S Howard; Soren Mellemkjaer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-21       Impact factor: 4.733

4.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

5.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

6.  Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension.

Authors:  Amy L Firth; Weijuan Yao; Aiko Ogawa; Michael M Madani; Grace Y Lin; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-24       Impact factor: 4.249

Review 7.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 8.  [Thromboembolism and pulmonary hypertension].

Authors:  D Drömann
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

Review 9.  Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.

Authors:  Timothy M Fernandes; David S Poch; William R Auger
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 10.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.